|
Eight-year outcomes of a phase III randomized trial of conventional versus hypofractionated high-dose intensity modulated radiotherapy for prostate cancer (CRUK/06/016): Update from the CHHiP Trial. |
|
|
Honoraria - Janssen; Sandoz; Takeda |
Consulting or Advisory Role - Cadence Research and Consulting; FirstWord; Janssen; Janssen Research & Development; Sandoz; Takeda |
Speakers' Bureau - Janssen; Janssen-Cilag |
Patents, Royalties, Other Intellectual Property - Abiraterone acetate was developed at The Institute of Cancer Research, which therefore has a commercial interest in the development of this agent. Professor Dearnaley is on the Institute’s Rewards to Inventors list for abiraterone acetate. (Inst); Patent issued EP1933709B1 (location and stabilisation device) |
Expert Testimony - Vitality Life |
Travel, Accommodations, Expenses - Janssen; Takeda |
|
|
Research Funding - Accuray (Inst) |
|
|
Travel, Accommodations, Expenses - Bayer |
|
|
Stock and Other Ownership Interests - Genesis Cancer Care |
Consulting or Advisory Role - Accuray; Astellas Oncology; Bayer; Boston Scientific; Janssen |
Speakers' Bureau - Accuray; Astellas Oncology; Bayer; Boston Scientific; Janssen |
Travel, Accommodations, Expenses - Accuray; Astellas Oncology; Bayer; Boston Scientific; Janssen |
|
|
Honoraria - Janssen-Cilag |
Consulting or Advisory Role - Astellas Medivation; AstraZeneca; Bayer Schering Pharma; Janssen Oncology; Roche; Sanofi |
|
|
Honoraria - American Society of Therapeutic Radiation Oncology; Bayer; Bayer; Elekta; Janssen Oncology |
Research Funding - Cancer Research UK; Elekta (Inst); NIHR; Prostate Cancer UK |
Travel, Accommodations, Expenses - Bayer; Elekta |
|
|
No Relationships to Disclose |
|
|
Research Funding - Bayer (Inst); Millennium (Inst); Teva (Inst) |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Research Funding - Accuray (Inst) |
|
|
No Relationships to Disclose |
|
|
Research Funding - Accuray (Inst) |
|
|
Research Funding - Accuray (Inst); Alliance Pharma (Inst); AstraZeneca (Inst); Aventis Pharma (Inst); Bayer Health (Inst); Kyowa Hakko Kirin (Inst); Merck Sharp & Dohme (Inst) |